Sarah Kostiuk-Smith, Partner and Patent Attorney at Mewburn Ellis, joins Forward Editor Caitlin Mackesy Davies to tackle the topic of patent validation strategies, focusing on the pharmaceutical sector in Europe. Sarah gives us a glimpse into the key findings of the Special Report she has recently co-authored on the topic, along with the reasons why it will be of interest to pharmaceutical firms ranging from Big Pharma down to small innovative start-ups.
Listen time: 11 minutes
Episode guide
- Episode intro (00:17)
- What is patent validation? (00:57)
- The do or die moment (02:37)
- Why is it useful to investigate the topic of validation strategies for pharma patents? (03:12)
- Where to begin in terms of deciding where to validate a pharma patent (04:30)
- Differences between the approach of Big Pharma to smaller companies (06:27)
- Key takeaways from the Special Report (07:08)
Useful links
Download the Special Report: Validation Strategies for Pharmaceutical Patents in Europe
Visit our pharma spotlight page for more information on the topic and view our blog series.
More about Mewburn Ellis Forward
Forward celebrates the most compelling developments taking place in the scientific and entrepreneurial worlds and covers the IP challenges that international organisations face every day. This podcast is part of our new Forward: On Demand series - video blogs (vlogs), podcasts and webinars available to watch or listen to at any time. View the full series here and the podcast series here.
Sign up to our monthly Forward newsletter to receive the latest news, insights, features and on demand content direct to your inbox each month.
Our People
Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.
